Hypertension
3rd Edition
Published on 31. October 2022
Book
Paperback/Softback
288 pages
978-0-19-887067-8 (ISBN)
Description
The management of hypertension varies considerably from clinician to clinician. This pocketbook is a concise and evidence-based summary of current understanding and practice, including the most up-to-date guidance from national and international bodies and their recommendations for hypertension care.
Written by an international team of experts, it covers all the key aspects of hypertension from epidemiology and aetiology to investigations, management, and complications. It also covers the management of hypertension in special patient groups such as in pregnancy and the elderly. Emphasis is laid throughout the book on lowering cardiovascular risk as a part of managing hypertension. An essential tool for everyday use in managing hypertension, this book aids clinical decision-making by collating all the relevant information and guidance in one easily accessible place.
This new edition has been fully updated to include expanded content on hypertension mediated organ damage and two new chapters covering the effects of hypertension on the brain and on the eyes.
Written by an international team of experts, it covers all the key aspects of hypertension from epidemiology and aetiology to investigations, management, and complications. It also covers the management of hypertension in special patient groups such as in pregnancy and the elderly. Emphasis is laid throughout the book on lowering cardiovascular risk as a part of managing hypertension. An essential tool for everyday use in managing hypertension, this book aids clinical decision-making by collating all the relevant information and guidance in one easily accessible place.
This new edition has been fully updated to include expanded content on hypertension mediated organ damage and two new chapters covering the effects of hypertension on the brain and on the eyes.
More details
Series
Edition
3rd Revised edition
Language
English
Place of publication
Oxford
United Kingdom
Target group
Professional and scholarly
Edition type
Revised edition
Product notice
Paperback (trade)
Unsewn / adhesive bound
Dimensions
Height: 211 mm
Width: 142 mm
Thickness: 23 mm
Weight
386 gr
ISBN-13
978-0-19-887067-8 (9780198870678)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Sunil Nadar | Gregory Lip
Hypertension
E-Book
10/2022
3rd Edition
OUP eBook
€30.49
Available for download
Sunil Nadar | Gregory Lip
Hypertension
E-Book
10/2022
3rd Edition
OUP eBook
€30.49
Available for download
Persons
Sunil K Nadar is a Consultant Cardiologist at Sultan Qaboos University Hospital in Muscat, Oman. Prior to this he worked as a Consultant Cardiologist at the NHS in Birmingham, UK. He did his research MD on platelet activation in hypertension and completed his specialist cardiology training in the West Midlands, UK. Dr Nadar is a Co-Editor with the Journal of Human Hypertension and an Associate Editor with the Sultan Qaboos University Medical Journal. He is currently involved in research work investigating the effects of thalassemia on the heart, the psychological impact of admission on patients with heart disease, and community awareness of the dangers of high dietary salt intake. He is also the coordinator for the May Measurement Month programme in Oman.
Gregory Y.H. Lip, is Price-Evans Chair of Cardiovascular Medicine at the University of Liverpool and Director of the Liverpool Centre for Cardiovascular Science at the University of Liverpool and Liverpool Heart & Chest Hospital, UK. He is also Distinguished Professor at Aalborg University, Denmark, and Adjunct Professor at Seoul National University and Yonsei University, Seoul, Korea. In 2014 Professor Lip was ranked by Expertscape as the world's leading expert in the understanding and treatment of Atrial Fibrillation. He was on the writing committee for various international guidelines and has acted at a senior editorial level for major international textbooks and journals. Professor Lip's current research interests range from epidemiology to pathophysiology, translational research, clinical risk assessment and trajectories of risk, patient management pathways, and applied health research.
Gregory Y.H. Lip, is Price-Evans Chair of Cardiovascular Medicine at the University of Liverpool and Director of the Liverpool Centre for Cardiovascular Science at the University of Liverpool and Liverpool Heart & Chest Hospital, UK. He is also Distinguished Professor at Aalborg University, Denmark, and Adjunct Professor at Seoul National University and Yonsei University, Seoul, Korea. In 2014 Professor Lip was ranked by Expertscape as the world's leading expert in the understanding and treatment of Atrial Fibrillation. He was on the writing committee for various international guidelines and has acted at a senior editorial level for major international textbooks and journals. Professor Lip's current research interests range from epidemiology to pathophysiology, translational research, clinical risk assessment and trajectories of risk, patient management pathways, and applied health research.
Content
Part 1: Epidemiology, pathogenesis and diagnosis
1: Sunil K. Nadar and Stephanie Harrison: Epidemiology of hypertension
2: Sheon Mary, Giacomo Rossitto, and Christian Delles: Pathophysiology of hypertension
3: Gurbhej Singh and Gurpreet Wander: Secondary hypertension
4: Martin Wolley and Michael Stowasser: Diagnosis and investigation of hypertension
Part 2: Complications of hypertension
5: Thomas Salmon, James Hatherley, and Rajiv Sankaranarayanan: Hypertension: a cardiovascular risk factor
6: Yuichiro Yano and Sunil K. Nadar: Left ventricular hypertrophy
7: Mohammed Najeeb Al-Rawahi: Atrial fibrillation and hypertension
8: Arun R. Gujjar: The brain in Hypertension
9: Sarah Ahmad and Jordana B. Cohen: The kidneys in hypertension
10: Peck Lin Lip: The eye in hypertension
Part 3: Management of hypertension
11: Gregory Y.H. Lip and Sunil K. Nadar: Overview of the guidelines on the management of hypertension
12: James P. Sheppard and Sunil K. Nadar: Hypertension and cardiovascular risk management
13: Benjamin J.R. Buckley and Stephanie J. Finnie: Non-pharmacological management of hypertension
14: Harsh Goel and Ashish Kumar: Diuretics in hypertension
15: Hatim Al Lawati: Beta blockers in hypertension
16: Stefanie Lip and Sandosh Padmanabhan: Calcium channel blockers and hypertension
17: Ify R. Mordi and Chim C. Lang: Blockers of the Renin- Angiotensin- Aldosterone system in hypertension
18: Shankar Patil, Muzahir Tayebjee, and Sunil K. Nadar: Other antihypertensive agents
19: Vikas Kapil: Renal denervation
20: Hassan Al-Riyami and Dierdre A. Lane: Improving medication adherence in hypertension
Part 4: Special conditions
21: Gloria Valdes: Hypertension in pregnancy: Physiopathological, preventive, therapeutic and long-term considerations
22: Alena Shantsila: Hypertensive emergencies
23: Asangaedem Akpan: Treatment of the older adult
24: Fang-Fei Wei, Chen Liu, and Jan A. Staessen: Diagnosis and management of resistant hypertension
25: Daniel J. Cuthbertson: Hypertension in patients with diabetes mellitus
1: Sunil K. Nadar and Stephanie Harrison: Epidemiology of hypertension
2: Sheon Mary, Giacomo Rossitto, and Christian Delles: Pathophysiology of hypertension
3: Gurbhej Singh and Gurpreet Wander: Secondary hypertension
4: Martin Wolley and Michael Stowasser: Diagnosis and investigation of hypertension
Part 2: Complications of hypertension
5: Thomas Salmon, James Hatherley, and Rajiv Sankaranarayanan: Hypertension: a cardiovascular risk factor
6: Yuichiro Yano and Sunil K. Nadar: Left ventricular hypertrophy
7: Mohammed Najeeb Al-Rawahi: Atrial fibrillation and hypertension
8: Arun R. Gujjar: The brain in Hypertension
9: Sarah Ahmad and Jordana B. Cohen: The kidneys in hypertension
10: Peck Lin Lip: The eye in hypertension
Part 3: Management of hypertension
11: Gregory Y.H. Lip and Sunil K. Nadar: Overview of the guidelines on the management of hypertension
12: James P. Sheppard and Sunil K. Nadar: Hypertension and cardiovascular risk management
13: Benjamin J.R. Buckley and Stephanie J. Finnie: Non-pharmacological management of hypertension
14: Harsh Goel and Ashish Kumar: Diuretics in hypertension
15: Hatim Al Lawati: Beta blockers in hypertension
16: Stefanie Lip and Sandosh Padmanabhan: Calcium channel blockers and hypertension
17: Ify R. Mordi and Chim C. Lang: Blockers of the Renin- Angiotensin- Aldosterone system in hypertension
18: Shankar Patil, Muzahir Tayebjee, and Sunil K. Nadar: Other antihypertensive agents
19: Vikas Kapil: Renal denervation
20: Hassan Al-Riyami and Dierdre A. Lane: Improving medication adherence in hypertension
Part 4: Special conditions
21: Gloria Valdes: Hypertension in pregnancy: Physiopathological, preventive, therapeutic and long-term considerations
22: Alena Shantsila: Hypertensive emergencies
23: Asangaedem Akpan: Treatment of the older adult
24: Fang-Fei Wei, Chen Liu, and Jan A. Staessen: Diagnosis and management of resistant hypertension
25: Daniel J. Cuthbertson: Hypertension in patients with diabetes mellitus